My Member
Message Center
trending topics
market reports
-
MEDICAL JAPAN 2025 OSAKA Returns to Showcase Global Innovations
2025-02-17
-
Visit MEDICAL JAPAN 2023 TOKYO and take full advantage of the business opportunities!
2023-09-01
-
US to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight
2022-01-21
-
Ethiopia receives additional 2.2 mln doses of Chinese-donated COVID-19 vaccines
2022-01-21
-
Hong Kong researchers say they develop novel material able to kill COVID-19 virus
2022-01-14
-
10 million more Chinese doses on way for Kenya
2022-01-14
-
Sino-African ties on track for a brighter future
2022-01-07
-
Efforts urged to boost COVID-19 vaccine production capacity in poor countries
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
Vaccine to undergo 3rd phase of trials
China began its first Phase 3 clinical trials of a recombinant subunit vaccine against COVID-19 on Wednesday, making it the fifth Chinese vaccine candidate to enter late-stage human testing.
2020-11-25 -
China's flu vaccine supply reaches five-year peak: Official
BEIJING -- China's flu vaccine production this year has doubled compared with last year, reaching a five-year high, an official with the National Health Commission said Thursday.
2020-11-13 -
Drug used to control blood pressure may improve cancer patients’ response to immunotherapy
The same biochemical triggers that spur a "fight or flight" response when we encounter threats may help tumor cells to thrive.
2020-11-06 -
China's centralized purchasing leads to 90% drop in price of coronary stents
TIANJIN - Coronary stents, once priced at more than 10,000 yuan (about $1,500) each, are expected to become available in Chinese hospitals at roughly 1,000 yuan for the treatment of coronary heart disease.
2020-11-06 -
United States is falling behind in the health care of older population, study shows
An international study led by UCLA Fielding School of Public Health researchers has determined that the United States is far from the most effective healthcare provider for those 50 and older among 23 countries.
2020-11-04 -
Vaccine makers might need insurance
Experts have welcomed a draft regulation on compulsory insurance for Chinese vaccine manufacturers, saying it will better protect the legal rights of vaccine recipients and strengthen oversight of the industry.
2020-10-30 -
COVID effects push healthcare into digital embrace
The COVID-19 pandemic has prompted the digital transformation and innovation in China's healthcare industry, experts said.
2020-10-29 -
China publishes quality standards for geo-authentic TCM herbs
BEIJING, Oct. 21 (Xinhua) -- China has published a compilation of standards to regulate the quality of over 150 kinds of geo-authentic traditional Chinese medicine (TCM) herbs and drug materials.
2020-10-22 -
China’s earliest vaccine volunteers conclude 6-month observation, set for second dose
The six-month follow-up medical observation for China's first batch of COVID-19 vaccine volunteers ends on the weekend, as the volunteers complete the final blood sample collection to see antibody levels.
2020-09-28 -
Fourth large-scale COVID-19 vaccine trial starts in US
WASHINGTON - A fourth Phase 3 clinical trial evaluating an investigational COVID-19 vaccine has begun enrolling adult volunteers, the U.S. National Institutes of Health (NIH) announced on Wednesday.
2020-09-24